发明名称 Process for preparating ivabradine hydrochloride form IV and methods of treatment of disease using ivabradine hydrochloride form IV
摘要 Ivabradine hydrochloride Form IV, its pharmaceutical composition, process for its preparation, and its use as therapeutically active ingredient and pharmaceutical compositions containing Ivabradine hydrochloride Form IV.
申请公布号 US9309201(B2) 申请公布日期 2016.04.12
申请号 US201514806224 申请日期 2015.07.22
申请人 URQUIMA, S.A. 发明人 Prohens Lopez Rafael;Puigjaner Vallet Cristina;Barbas Canero Rafael;Del Rio Pericacho Jose Luis;Marti Via Josep
分类号 C07D223/16;A61K9/28;A61K9/20;A61K31/55 主分类号 C07D223/16
代理机构 The Roy Gross Law Firm, LLC 代理人 The Roy Gross Law Firm, LLC ;Gross Roy
主权项 1. A process for preparing ivabradine hydrochloride Form IV with a powder X-ray diffraction comprising the following degrees 2 theta (±0.2) peaks: 8.74, 15.55, 17.17, 19.89, and 24.29, wherein the X-ray diffraction is measured using a CuKα radiation, the process comprising: a) slurrying ivabradine hydrochloride in a solvent system comprising toluene, ethanol, acetone, methyl ethyl ketone, methyl isobutyl ketone, ethyl acetate, isopropyl acetate and mixtures thereof; wherein said step of slurrying ivabradine occurs at a temperature of lower than 60° C. and the reaction time for said step of slurrying ivabradine is less than 48 h; and b) isolating the ivabradine hydrochloride Form IV.
地址 Barcelona ES